Overview
- 18 inspections across 17 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-10-11.
At a glance
Inspections
18
Sites
17
Observations
2
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| GlaxoSmithKline Biologicals SA | 11 Oct 2019 | Biologics | |
| AVEXIS | 8 Feb 2019 | Biologics | On file |
| Baxalta US Inc. | 2 Mar 2018 | Biologics | On file |
| Unigen Inc. | 15 Jun 2017 | Biologics | On file |
| LFB USA, Inc. | 12 May 2017 | Biologics | On file |
Sites inspected
GlaxoSmithKline Biologicals SAWavre, Belgium1 insp.
AVEXISLibertyville, United States1 insp.
Baxalta US Inc.Social Circle, United States1 insp.
Unigen Inc.Ibi-Gun, Japan1 insp.
LFB USA, Inc.Charlton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michele L Forster2 shared
Rabia Ballica2 shared
Tod J Merkel1 shared
Gregory A Price1 shared
Angela S Whatley1 shared
Andrew P Byrnes1 shared
Wei Wang1 shared
Burnell M Henry1 shared
Silvia Wanis1 shared
Yonggang Wang1 shared
Full investigator report
Get the verbatim findings behind Deborah M Trout's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site